|
|
|
 |
Tatsuzo Ishigami
Ph.D., Partner
CEO of STI International, Inc., a consulting firm in 1998. Actively involved in biotechnology and health care industries as the leading consultant. Vast knowledge in both realms, and has global human network. Possesses customers ?both leading companies and start-ups - from all over the world.
Established Clontech Laboratories, KK, a subsidiary of American molecular biology research products manufacturer in 1998 and had acted as itfs President & CEO.
Joined the leading clinical testing lab company, SRL, Inc. in 1986. Held positions such as the deputy director of the central laboratories, executive director of the product development and frontier business development. Undertook therapeutic businesses such as cell therapy and gene therapy in developing new bio-medical businesses. Also as the executive director of international business, holds a wide network with some hundred bio-venture companies in the world.
Joined Bristol-Myers, KK in 1977. Worked on reference laboratory service business as the manager of biochemical testing and the director of business. Expertise in laboratory and diagnostic product businesses.
Became TA of Aoyama Gakuin University, Dept. of Science and Engineering, Chemistry, in 1974.
Graduated from Noyori Laboratory of Nagoya University, Dept. of Science, Chemistry, Sophia University Graduate School, Doctorate of Science.
[ return to the team ]
|
|
|
